The prostate-specific antigen (PSA) and transrectal ultrasound biopsy approach for detection of prostate cancer (PCa) has resulted in a stage shift in terms of earlier diagnosis (Hankey et al, 1999). The gene discussed is KLK3; the disease is prostate cancer.